AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2015
Oct 23, 2015
29864_dirs_2015-10-23_cad10ad5-7bbe-49cf-b3bd-2e230a077881.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2015-10-21
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-21 | Common Stock | M | 10400 | $35.64 | Acquired | 355684 | Direct |
| 2015-10-21 | Common Stock | S | 1300 | $106.85 | Disposed | 354384 | Direct |
| 2015-10-21 | Common Stock | S | 4404 | $108.03 | Disposed | 349980 | Direct |
| 2015-10-21 | Common Stock | S | 1396 | $109.14 | Disposed | 348584 | Direct |
| 2015-10-21 | Common Stock | S | 2000 | $110.08 | Disposed | 346584 | Direct |
| 2015-10-21 | Common Stock | S | 1000 | $110.98 | Disposed | 345584 | Direct |
| 2015-10-21 | Common Stock | S | 300 | $112.00 | Disposed | 345284 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-21 | Stock Option (right to buy) | $35.64 | M | 10400 | Disposed | 2016-02-01 | Common Stock (10400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
| Common Stock | 122700 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3: Open market sales reported on this line occurred at a weighted average price of $106.85 (range $106.58 to $107.18).
F4: Open market sales reported on this line occurred at a weighted average price of $108.03 (range $107.59 to $108.58).
F5: Open market sales reported on this line occurred at a weighted average price of $109.14 (range $108.64 to $109.63).
F6: Open market sales reported on this line occurred at a weighted average price of $110.08 (range $109.64 to $110.56).
F7: Open market sales reported on this line occurred at a weighted average price of $110.98 (range $110.75 to $111.54).
F8: Open market sales reported on this line occurred at a weighted average price of $112.00 (range $112.00 to $112.01).
F9: Fully vested.